34th AM (2023) - Poster Session-Predictors of Treatment Admissions for Hallucinogen Use in the United States

Predictors of Treatment Admissions for Hallucinogen Use in the United States

Pdf Summary

A study conducted by the Department of Psychiatry at Phoenixville Hospital - Tower Health and Drexel University College of Medicine aimed to identify predictors of treatment admissions related to hallucinogen use in the United States. Hallucinogens have garnered attention for their potential in treating psychiatric disorders and can induce altered states of consciousness. The study analyzed data from the Treatment Episode Data Set Admissions (TEDS-A) 2020, which represents admissions to substance abuse treatment facilities receiving public funding. The substances included in the analysis were LSD, DMT, mescaline, peyote, psilocybin, STP, and other hallucinogens. <br /><br />The findings revealed that out of 1,416,357 treatment admissions, only 0.6% were associated with hallucinogen use. It was observed that a higher percentage of males reported hallucinogen use at admission compared to females. Additionally, participants aged 12-29 had a higher percentage of hallucinogen use at admission compared to older age groups. The study also found a significant association between cannabis use and hallucinogen use at admission.<br /><br />The predictors of treatment admissions for hallucinogen use identified in the study included co-occurring mental health and substance use disorders, male gender, African American race, unemployment, homelessness, and having a bachelor's degree. These factors were associated with higher odds of admission for hallucinogen use.<br /><br />The study suggests that further research is needed to understand the factors contributing to the development of hallucinogen use disorder and the occurrence of treatment episodes, given the increasing popularity and recognized therapeutic potential of hallucinogens.

Keywords

hallucinogen use

treatment admissions

predictors

psychiatric disorders

altered states of consciousness

data analysis

LSD

DMT

cannabis use

co-occurring disorders

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org	About Advocacy Membership Fellowship Education and Resources Training Events